Item 8.01 Other Events.

On December 27, 2021, United States District Court for the Western District of Texas, Waco Division (the "Court") granted Intel Corporation's motion to dismiss the patent infringement claims asserted against Intel by Health Discovery Corporation (the "Company"). The Court's reasoning, as set forth in its opinion, is based on its interpretation of the two-step framework established by the U.S. Supreme Court in Alice Corp. Pty. v. CLS Bank Int'l, 573 U.S. 208 (2014).

The Court's dismissal is without prejudice, meaning that the Company may refile the case and include additional allegations in the complaint.

The Company disagrees with the ruling and is currently evaluating its next steps in the patent litigation. The Company will continue to evaluate and fight for the rights of the Company and its shareholders. As with many legal matters, it is difficult to predict outcomes and therefore any assumption of success cannot be assured.

Item 9.01 Financial Statements and Exhibits





  (a) Not applicable




  (b) Not applicable




  (c) Not applicable




  (d) Exhibits

Exhibit 99.1 - MEMORANDUM OPINION AND ORDER GRANTING-IN-PART AND DENYING-AS-MOOT-IN-PART INTEL CORPORATION'S MOTION TO DISMISS

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).











  2

© Edgar Online, source Glimpses